The results from micro-CT and histomorphometric evaluation showed that the trabecular microstructure and bone regeneration of the insulin-treated T2DM group were improved to a certain extent, but there was no comparability to controls. The gene discussed is INS; the disease is type 2 diabetes mellitus.